Evolus Revenue 2016-2025 | EOLS

Evolus revenue from 2016 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Evolus Annual Revenue
(Millions of US $)
2024 $266
2023 $202
2022 $149
2021 $100
2020 $57
2019 $35
2018 $0
2017 $0
2016 $0
2015 $0
Evolus Quarterly Revenue
(Millions of US $)
2025-03-31 $69
2024-12-31 $79
2024-09-30 $61
2024-06-30 $67
2024-03-31 $59
2023-12-31 $61
2023-09-30 $50
2023-06-30 $49
2023-03-31 $42
2022-12-31 $44
2022-09-30 $34
2022-06-30 $37
2022-03-31 $34
2021-12-31 $35
2021-09-30 $27
2021-06-30 $26
2021-03-31 $12
2020-12-31 $21
2020-09-30 $18
2020-06-30 $8
2020-03-31 $10
2019-12-31 $19
2019-09-30 $13
2019-06-30 $2
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.614B $0.266B
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $220.159B 25.82
Boston Scientific (BSX) United States $157.028B 37.51
Stryker (SYK) United States $154.023B 32.21
EssilorLuxottica (ESLOY) France $136.572B 0.00
Medtronic (MDT) Ireland $119.200B 16.90
Lonza Group Ag (LZAGY) Switzerland $50.282B 0.00
Haleon (HLN) United Kingdom $44.384B 25.33
ResMed (RMD) United States $40.346B 30.30
GE HealthCare Technologies (GEHC) United States $35.536B 16.87
Agilent Technologies (A) United States $34.139B 22.26
Terumo (TRUMY) Japan $25.843B 33.57
Koninklijke Philips (PHG) Netherlands $25.190B 17.68
Insulet (PODD) United States $20.424B 80.17
Zimmer Biomet Holdings (ZBH) United States $19.300B 12.40
Baxter (BAX) United States $14.995B 11.20
Smith & Nephew SNATS (SNN) United Kingdom $13.871B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.189B 25.02
Lantheus Holdings (LNTH) United States $5.046B 12.73
Perrigo (PRGO) Ireland $3.908B 9.91
Prestige Consumer Healthcare (PBH) United States $3.799B 16.97
Haemonetics (HAE) United States $3.613B 16.46
Envista Holdings (NVST) United States $3.525B 29.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.197B 23.58
LeMaitre Vascular (LMAT) United States $1.862B 41.63
QuidelOrtho (QDEL) United States $1.852B 12.74
AtriCure (ATRC) United States $1.559B 0.00
Acuren (TIC) United States $1.441B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.95
AdaptHealth (AHCO) United States $1.274B 12.93
Phibro Animal Health (PAHC) United States $1.183B 15.12
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.080B 0.00
Curaleaf Holdings (CURLF) Canada $0.964B 0.00
InMode (INMD) Israel $0.930B 9.38
Kestra Medical Technologies (KMTS) United States $0.850B 0.00
Tilray Brands (TLRY) Canada $0.693B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.685B 0.00
Valneva SE (VALN) France $0.654B 0.00
Owens & Minor (OMI) United States $0.609B 5.05
CeriBell (CBLL) United States $0.547B 0.00
ZimVie (ZIMV) United States $0.521B 23.70
Surmodics (SRDX) United States $0.515B 0.00
SNDL (SNDL) Canada $0.398B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.359B 0.00
Cresco Labs (CRLBF) United States $0.336B 0.00
Sanuwave Health (SNWV) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Capricor Therapeutics (CAPR) United States $0.322B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Aurora Cannabis (ACB) Canada $0.272B 80.67
Cerus (CERS) United States $0.266B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.242B 20.40
Biote (BTMD) United States $0.236B 6.65
Canopy Growth (CGC) Canada $0.234B 0.00
Verano Holdings (VRNOF) United States $0.230B 0.00
Sanara MedTech (SMTI) United States $0.227B 0.00
Omeros (OMER) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Organigram Global (OGI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.190B 15.65
High Tide (HITI) Canada $0.188B 0.00
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.155B 0.00
TerrAscend (TSNDF) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.121B 14.91
MacroGenics (MGNX) United States $0.108B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Jushi Holdings (JUSHF) United States $0.101B 0.00
Fonar (FONR) United States $0.100B 12.86
Quipt Home Medical (QIPT) United States $0.097B 0.00
Apyx Medical (APYX) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.082B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 13.29
Nephros (NEPH) United States $0.038B 51.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00